RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Provision for income taxes

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥103.3B
P/E ratio
19.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndProvision for income taxes (Million JPY)YoY (%)
Mar 31, 20253,684+117.22%
Mar 31, 20241,696-22.27%
Mar 31, 20232,182+69.94%
Mar 31, 20221,284-42.21%
Mar 31, 20212,222+5.51%
Mar 31, 20202,106-15.42%
Mar 31, 20192,490+0.16%
Mar 31, 20182,486+3.11%
Mar 31, 20172,411-53.41%
Mar 31, 20165,175-5.86%
Mar 31, 20155,497

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)